Inorganic arsenite-induced malignant transformation of human prostate epithelial cells
- PMID: 12488483
- DOI: 10.1093/jnci/94.24.1888
Inorganic arsenite-induced malignant transformation of human prostate epithelial cells
Abstract
Although several epidemiologic studies show an association between arsenic exposure and prostate cancer, it is still unknown whether human prostate epithelial cells are directly susceptible to arsenic-induced transformation. This study was designed to determine whether the nontumorigenic human prostate epithelial cell line RWPE-1 could be malignantly transformed in vitro by arsenite. RWPE-1 cells were continuously exposed to 5 micro M arsenite and monitored for signs of transformation, assessed as changes in matrix metalloproteinase-9 levels. After 29 weeks of exposure, the arsenite-exposed RWPE-1 cells (referred to as CAsE-PE) showed a marked increase in matrix metalloproteinase-9 secretion, a common finding in prostate malignancies. Malignant transformation was confirmed when CAsE-PE cells produced aggressive undifferentiated malignant epithelial tumors in nude mice. The tumors stained positive for human prostate-specific antigen, confirming their origin. These results are the first report of arsenite-induced malignant transformation of a human epithelial cell line and provide an important in vitro model for studying the mechanisms underlying arsenic-induced carcinogenesis in humans.
Similar articles
-
Arsenic-induced prostate cancer: an enigma.Med Oncol. 2024 Jan 6;41(2):50. doi: 10.1007/s12032-023-02266-5. Med Oncol. 2024. PMID: 38184511 Review.
-
Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.Toxicol Appl Pharmacol. 2005 Aug 15;206(3):288-98. doi: 10.1016/j.taap.2004.11.017. Epub 2005 Jan 18. Toxicol Appl Pharmacol. 2005. PMID: 16039940
-
Arsenic-specific stem cell selection during malignant transformation.J Natl Cancer Inst. 2010 May 5;102(9):638-49. doi: 10.1093/jnci/djq093. Epub 2010 Mar 25. J Natl Cancer Inst. 2010. PMID: 20339138 Free PMC article.
-
Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.Toxicol Appl Pharmacol. 2001 Sep 15;175(3):260-8. doi: 10.1006/taap.2001.9253. Toxicol Appl Pharmacol. 2001. PMID: 11559025
-
Inorganic arsenic and human prostate cancer.Environ Health Perspect. 2008 Feb;116(2):158-64. doi: 10.1289/ehp.10423. Environ Health Perspect. 2008. PMID: 18288312 Free PMC article. Review.
Cited by
-
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.Epigenetics. 2012 Nov;7(11):1238-48. doi: 10.4161/epi.22163. Epub 2012 Sep 13. Epigenetics. 2012. PMID: 22976526 Free PMC article.
-
Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype.Toxicol Sci. 2018 Sep 1;165(1):40-49. doi: 10.1093/toxsci/kfy176. Toxicol Sci. 2018. PMID: 30169766 Free PMC article.
-
Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol.ACS Omega. 2018 May 31;3(5):5511-5515. doi: 10.1021/acsomega.7b01727. Epub 2018 May 21. ACS Omega. 2018. PMID: 29876539 Free PMC article.
-
Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.Toxicol Appl Pharmacol. 2016 Dec 1;312:11-18. doi: 10.1016/j.taap.2015.12.013. Epub 2015 Dec 22. Toxicol Appl Pharmacol. 2016. PMID: 26721309 Free PMC article.
-
Arsenic-induced prostate cancer: an enigma.Med Oncol. 2024 Jan 6;41(2):50. doi: 10.1007/s12032-023-02266-5. Med Oncol. 2024. PMID: 38184511 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources